Molecule Details
InChIKeyLSXUTRRVVSPWDZ-MKKUMYSQSA-N
Compound NameXevinapant
Canonical SMILESCN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CC(C)C)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Homologous
Avg pChEMBL7.38
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB16305
Drug NameXevinapant
CAS Number1071992-99-8
Groups investigational
ATC Codes nan
Descriptionnan

Categories: Benzene Derivatives
Cross-references: BindingDB: 50393505 CHEMBL2158051 ChemSpider: 28424114 ZINC: ZINC000043208643
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
Q13490 BIRC2 Homo sapiens Human PF00653 PF00619 PF21290 PF13920 7.5 IC50 ChEMBL;BindingDB
Q13489 BIRC3 Homo sapiens Human PF00653 PF00619 PF21290 PF13920 7.4 IC50 ChEMBL;BindingDB
P98170 XIAP Homo sapiens Human PF00653 PF21290 PF13920 7.3 IC50 ChEMBL;BindingDB
DrugBank Target Actions (6)
Target Gene Target Name Action Type
O15392 O15392 Baculoviral IAP repeat-containing protein 5 modulator targets
P98170 XIAP E3 ubiquitin-protein ligase XIAP modulator targets
Q13075 Q13075 Baculoviral IAP repeat-containing protein 1 modulator targets
Q13489 BIRC3 Baculoviral IAP repeat-containing protein 3 modulator targets
Q13490 BIRC2 Baculoviral IAP repeat-containing protein 2 modulator targets
Q96CA5 BIRC7 Baculoviral IAP repeat-containing protein 7 modulator targets